Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2013

Open Access 01-12-2013 | Research article

Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer

Authors: Yoshiki Kozu, Tomohiro Maniwa, Shoji Takahashi, Mitsuhiro Isaka, Yasuhisa Ohde, Takashi Nakajima

Published in: Journal of Cardiothoracic Surgery | Issue 1/2013

Login to get access

Abstract

Background

Until date, there are no clear recommendations for regular perioperative measurements of serum CEA levels for lung cancer in any guidelines. The purpose in the present study is to evaluate the prognostic significance of perioperative serum carcinoembryonic antigen (CEA) levels in patients with pathological-stage I non-small cell lung cancer (NSCLC).

Methods

We retrospectively reviewed 263 completely resected pathological-stage I NSCLC patients whose preoperative and postoperative serum CEA levels were measured. Patients were subdivided according to the perioperative change of CEA levels: continuously normal CEA levels (NN group), continuously high CEA levels (HH group), and high preoperative CEA levels that returned to normal levels post-operation (HN group). The clinicopathological factors and overall survival (OS) among these 3 groups were compared. Univariate and multivariate analyses of the correlation between clinicopathological factors and OS were performed.

Results

High preoperative CEA levels significantly correlated with men aged >70 years with smoking history, high serum CYFRA 21–1 levels, greater tumor diameter, presence of visceral pleural invasion (VPI), and moderate-to-poor differentiation. Five-year OS rates in the NN and HH groups were 95.5% and 59.3%, respectively. Four-year OS rate in the HN group was 85.5%. Multivariate analyses indicated tumor diameter of more than 30 mm, presence of VPI, and the HH group were independent unfavorable prognostic factors.

Conclusions

A high postoperative CEA level was an independent unfavorable prognostic factor in pathological-stage I NSCLC patients. Patients with high postoperative CEA levels may benefit from adjuvant chemotherapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Inoue M, Minami M, Shiono H, Sawabata N, Ideguchi K, Okumura M: Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg. 2006, 131: 988-993. 10.1016/j.jtcvs.2005.12.035.CrossRefPubMed Inoue M, Minami M, Shiono H, Sawabata N, Ideguchi K, Okumura M: Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg. 2006, 131: 988-993. 10.1016/j.jtcvs.2005.12.035.CrossRefPubMed
2.
go back to reference Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N: Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2007, 32: 435-439. 10.1016/j.ejcts.2007.05.014.CrossRefPubMed Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N: Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2007, 32: 435-439. 10.1016/j.ejcts.2007.05.014.CrossRefPubMed
3.
go back to reference Muley T, Dienemann H, Ebert W: CYFRA 21–1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients. Anticancer Res. 2004, 24: 1953-1956.PubMed Muley T, Dienemann H, Ebert W: CYFRA 21–1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients. Anticancer Res. 2004, 24: 1953-1956.PubMed
4.
go back to reference Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N: Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg. 2004, 78: 216-221. 10.1016/j.athoracsur.2004.02.009.CrossRefPubMed Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N: Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg. 2004, 78: 216-221. 10.1016/j.athoracsur.2004.02.009.CrossRefPubMed
5.
go back to reference Sakao Y, Tomimitsu S, Takeda Y, Natsuaki M, Itoh T: Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg. 2004, 25: 520-522. 10.1016/j.ejcts.2004.01.029.CrossRefPubMed Sakao Y, Tomimitsu S, Takeda Y, Natsuaki M, Itoh T: Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg. 2004, 25: 520-522. 10.1016/j.ejcts.2004.01.029.CrossRefPubMed
6.
go back to reference Sawabata N, Ohta M, Takeda S, Hirano H, Okumura Y, Asada H, Maeda H: Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg. 2002, 74: 174-179. 10.1016/S0003-4975(02)03662-7.CrossRefPubMed Sawabata N, Ohta M, Takeda S, Hirano H, Okumura Y, Asada H, Maeda H: Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg. 2002, 74: 174-179. 10.1016/S0003-4975(02)03662-7.CrossRefPubMed
7.
go back to reference Suzuki K, Nagai K, Yoshida J, Moriyama E, Nishimura M, Takahashi K, Nishiwaki Y: Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 1999, 67: 927-932. 10.1016/S0003-4975(99)00140-X.CrossRefPubMed Suzuki K, Nagai K, Yoshida J, Moriyama E, Nishimura M, Takahashi K, Nishiwaki Y: Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 1999, 67: 927-932. 10.1016/S0003-4975(99)00140-X.CrossRefPubMed
8.
go back to reference Yoshimasu T, Kokawa Y, Oura S, Hirai I, Sasaki R, Tanino H, Sakurai T, Okamura Y: Time course of carcinoembryonic antigen after resection of lung cancer: a predictor of recurrence. Cancer Sci. 2003, 94: 741-744. 10.1111/j.1349-7006.2003.tb01512.x.CrossRefPubMed Yoshimasu T, Kokawa Y, Oura S, Hirai I, Sasaki R, Tanino H, Sakurai T, Okamura Y: Time course of carcinoembryonic antigen after resection of lung cancer: a predictor of recurrence. Cancer Sci. 2003, 94: 741-744. 10.1111/j.1349-7006.2003.tb01512.x.CrossRefPubMed
9.
go back to reference Dent PB, McCulloch PB, Wesley-James O, MacLaren R, Muirhead W, Dunnett CW: Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma. Cancer. 1978, 42: 1484-1491. 10.1002/1097-0142(197809)42:3+<1484::AID-CNCR2820420819>3.0.CO;2-J.CrossRefPubMed Dent PB, McCulloch PB, Wesley-James O, MacLaren R, Muirhead W, Dunnett CW: Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma. Cancer. 1978, 42: 1484-1491. 10.1002/1097-0142(197809)42:3+<1484::AID-CNCR2820420819>3.0.CO;2-J.CrossRefPubMed
10.
go back to reference Kashiwabara K, Saeki S, Sasaki J, Nomura M, Kohrogi H: Combined evaluation of postoperative serum levels of carcinoembryonic antigen less than or equal to 2.5 ng/ml and absence of vascular invasion may predict no recurrence of stage I adenocarcinoma lung cancer. J Thorac Oncol. 2008, 3: 1416-1420. 10.1097/JTO.0b013e31818dda85.CrossRefPubMed Kashiwabara K, Saeki S, Sasaki J, Nomura M, Kohrogi H: Combined evaluation of postoperative serum levels of carcinoembryonic antigen less than or equal to 2.5 ng/ml and absence of vascular invasion may predict no recurrence of stage I adenocarcinoma lung cancer. J Thorac Oncol. 2008, 3: 1416-1420. 10.1097/JTO.0b013e31818dda85.CrossRefPubMed
11.
go back to reference Matsuguma H, Nakahara R, Igarashi S, Ishikawa Y, Suzuki H, Miyazawa N, Honjo S, Yokoi K: Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. J Thorac Cardiovasc Surg. 2008, 135: 44-49. 10.1016/j.jtcvs.2007.09.032.CrossRefPubMed Matsuguma H, Nakahara R, Igarashi S, Ishikawa Y, Suzuki H, Miyazawa N, Honjo S, Yokoi K: Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. J Thorac Cardiovasc Surg. 2008, 135: 44-49. 10.1016/j.jtcvs.2007.09.032.CrossRefPubMed
12.
go back to reference Nonaka M, Kataoka D, Yamamoto S, Bito A, Matsuoka J, Kawada T, Takaba T: Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma. Ann Thorac Cardiovasc Surg. 2004, 10: 281-284.PubMed Nonaka M, Kataoka D, Yamamoto S, Bito A, Matsuoka J, Kawada T, Takaba T: Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma. Ann Thorac Cardiovasc Surg. 2004, 10: 281-284.PubMed
13.
go back to reference Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T, Ito M: Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis. Cancer. 2004, 101: 803-809. 10.1002/cncr.20421.CrossRefPubMed Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T, Ito M: Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis. Cancer. 2004, 101: 803-809. 10.1002/cncr.20421.CrossRefPubMed
14.
go back to reference Tomita M, Matsuzaki Y, Shimizu T, Hara M, Ayabe T, Onitsuka T: Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels. Thorac Cardiovasc Surg. 2005, 53: 300-304. 10.1055/s-2005-865671.CrossRefPubMed Tomita M, Matsuzaki Y, Shimizu T, Hara M, Ayabe T, Onitsuka T: Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels. Thorac Cardiovasc Surg. 2005, 53: 300-304. 10.1055/s-2005-865671.CrossRefPubMed
15.
go back to reference Wang CY, Huang MS, Huang MH, Lee HC, Hsu HS: Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer. J Surg Res. 2010, 163: e45-e50. 10.1016/j.jss.2010.04.039.CrossRefPubMed Wang CY, Huang MS, Huang MH, Lee HC, Hsu HS: Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer. J Surg Res. 2010, 163: e45-e50. 10.1016/j.jss.2010.04.039.CrossRefPubMed
16.
go back to reference Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L: The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007, 2: 706-714. 10.1097/JTO.0b013e31812f3c1a.CrossRefPubMed Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L: The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007, 2: 706-714. 10.1097/JTO.0b013e31812f3c1a.CrossRefPubMed
17.
go back to reference Travis WD BE, HK M-H, Harris CC: World Health Organization classification of tumors: pathology and genetics of tumors of the lung, pleura, thymus and heart. 2004, Lyon: IARC Press Travis WD BE, HK M-H, Harris CC: World Health Organization classification of tumors: pathology and genetics of tumors of the lung, pleura, thymus and heart. 2004, Lyon: IARC Press
18.
go back to reference Bae SN, Namkoong SE, Jung JK, Kim CJ, Park JS, Kim JW, Lee JM, Kim SJ: Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1997, 64: 418-424. 10.1006/gyno.1996.4589.CrossRefPubMed Bae SN, Namkoong SE, Jung JK, Kim CJ, Park JS, Kim JW, Lee JM, Kim SJ: Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1997, 64: 418-424. 10.1006/gyno.1996.4589.CrossRefPubMed
19.
go back to reference Kosugi S, Nishimaki T, Kanda T, Nakagawa S, Ohashi M, Hatakeyama K: Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19–9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg. 2004, 28: 680-685.CrossRefPubMed Kosugi S, Nishimaki T, Kanda T, Nakagawa S, Ohashi M, Hatakeyama K: Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19–9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg. 2004, 28: 680-685.CrossRefPubMed
20.
go back to reference Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Yang SN, Lin FJ: Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix. Tumour Biol. 2008, 29: 255-261. 10.1159/000152943.CrossRefPubMed Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Yang SN, Lin FJ: Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix. Tumour Biol. 2008, 29: 255-261. 10.1159/000152943.CrossRefPubMed
21.
go back to reference Nagashima T, Sakao Y, Mun M, Ishikawa Y, Nakagawa K, Masuda M, Okumura S: A Clinicopathological Study of Resected Small-Sized Squamous Cell Carcinomas of the Peripheral Lung: Prognostic Significance of Serum Carcinoembryonic Antigen Levels. Ann Thorac Cardiovasc Surg. 2012 Nagashima T, Sakao Y, Mun M, Ishikawa Y, Nakagawa K, Masuda M, Okumura S: A Clinicopathological Study of Resected Small-Sized Squamous Cell Carcinomas of the Peripheral Lung: Prognostic Significance of Serum Carcinoembryonic Antigen Levels. Ann Thorac Cardiovasc Surg. 2012
22.
go back to reference Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H, Ochiai T: Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery. 2003, 133: 486-494. 10.1067/msy.2003.139.CrossRefPubMed Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H, Ochiai T: Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery. 2003, 133: 486-494. 10.1067/msy.2003.139.CrossRefPubMed
23.
go back to reference Buccheri G, Ferrigno D: Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test. Ann Thorac Surg. 2003, 75: 973-980. 10.1016/S0003-4975(02)04638-6.CrossRefPubMed Buccheri G, Ferrigno D: Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test. Ann Thorac Surg. 2003, 75: 973-980. 10.1016/S0003-4975(02)04638-6.CrossRefPubMed
24.
go back to reference Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Imaizumi M, Wada H: Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol. 2005, 23: 4999-5006. 10.1200/JCO.2005.09.017.CrossRefPubMed Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Imaizumi M, Wada H: Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol. 2005, 23: 4999-5006. 10.1200/JCO.2005.09.017.CrossRefPubMed
25.
go back to reference Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N: A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 2004, 350: 1713-1721. 10.1056/NEJMoa032792.CrossRefPubMed Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N: A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 2004, 350: 1713-1721. 10.1056/NEJMoa032792.CrossRefPubMed
26.
go back to reference Fukai R, Sakao Y, Sakuraba M, Oh S, Shiomi K, Sonobe S, Saitoh Y, Miyamoto H: The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Eur J Cardiothorac Surg. 2007, 32: 440-444. 10.1016/j.ejcts.2007.06.011.CrossRefPubMed Fukai R, Sakao Y, Sakuraba M, Oh S, Shiomi K, Sonobe S, Saitoh Y, Miyamoto H: The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Eur J Cardiothorac Surg. 2007, 32: 440-444. 10.1016/j.ejcts.2007.06.011.CrossRefPubMed
Metadata
Title
Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer
Authors
Yoshiki Kozu
Tomohiro Maniwa
Shoji Takahashi
Mitsuhiro Isaka
Yasuhisa Ohde
Takashi Nakajima
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2013
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/1749-8090-8-106

Other articles of this Issue 1/2013

Journal of Cardiothoracic Surgery 1/2013 Go to the issue